Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $3.74 Million - $4.3 Million
46,380 New
46,380 $3.97 Million
Q2 2023

Aug 15, 2023

SELL
$80.84 - $89.45 $4.35 Million - $4.82 Million
-53,870 Reduced 81.03%
12,610 $1.07 Million
Q1 2023

May 15, 2023

SELL
$72.75 - $90.6 $2.18 Million - $2.71 Million
-29,950 Reduced 31.06%
66,480 $5.5 Million
Q4 2022

Feb 09, 2023

SELL
$73.85 - $86.14 $436,453 - $509,087
-5,910 Reduced 5.77%
96,430 $7.58 Million
Q3 2022

Nov 15, 2022

BUY
$63.3 - $78.66 $1.22 Million - $1.52 Million
19,290 Added 23.23%
102,340 $7.58 Million
Q2 2022

Aug 16, 2022

BUY
$49.27 - $66.08 $4.09 Million - $5.49 Million
83,050 New
83,050 $5.41 Million
Q1 2020

May 13, 2020

SELL
$74.34 - $121.82 $6.12 Million - $10 Million
-82,292 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$114.37 - $129.46 $3.72 Million - $4.21 Million
-32,558 Reduced 28.35%
82,292 $9.46 Million
Q3 2019

Nov 15, 2019

BUY
$117.16 - $138.52 $12,887 - $15,237
110 Added 0.1%
114,850 $14.5 Million
Q2 2019

Aug 13, 2019

BUY
$81.74 - $120.34 $9.38 Million - $13.8 Million
114,740 New
114,740 $13.8 Million
Q1 2019

May 14, 2019

SELL
$83.25 - $102.12 $9.44 Million - $11.6 Million
-113,412 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$90.66 - $116.63 $4.43 Million - $5.69 Million
-48,810 Reduced 30.09%
113,412 $11.3 Million
Q3 2018

Nov 15, 2018

SELL
$89.96 - $114.58 $5.79 Million - $7.38 Million
-64,380 Reduced 28.41%
162,222 $18.6 Million
Q2 2018

Aug 15, 2018

SELL
$71.53 - $95.75 $554,643 - $742,445
-7,754 Reduced 3.31%
226,602 $20.3 Million
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $3.21 Million - $3.93 Million
52,861 Added 29.13%
234,356 $17.1 Million
Q4 2017

Feb 15, 2018

BUY
$44.96 - $58.99 $8.16 Million - $10.7 Million
181,495
181,495 $10.5 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.